Bolan Linghu Selected Research

Diarrhea

1/2019

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bolan Linghu Research Topics

Disease

3	Neoplasms (Cancer) 02/2021 - 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021
1	Lung Neoplasms (Lung Cancer) 02/2021
1	Diarrhea 01/2019
1	Cough 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Headache (Headaches) 01/2019
1	Retinal Degeneration 10/2015
1	Ciliopathies 10/2015
1	Macrophage Activation Syndrome 12/2014
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2014
1	Immune System Diseases (Immune Disorders) 12/2014
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2014

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 12/2014
1	LigandsIBA 01/2020
1	P-2 (P 2)IBA 01/2020
1	durvalumabIBA 01/2020
1	ibrutinibIBA 01/2019
1	acalabrutinibIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2015

Therapy/Procedure

1	Therapeutics 02/2021
1	Immunotherapy 02/2021